1
Janssen-Heijnen, Maryska L., van Steenbergen, Liza N., Steyerberg, Ewout, Visser, Otto, De Ruysscher, Dirk K., Groen, Harry J.
Veröffentlicht in: Janssen-Heijnen , M L , van Steenbergen , L N , Steyerberg , E , Visser , O , De Ruysscher , D K & Groen , H J 2012 , ' Long-Term Excess Mortality for Survivors of Non-small Cell Lung Cancer in the Netherlands ' , Journal of Thoracic Oncology , vol. 7 , no. 3 , pp. 496-502 . https://doi.org/10.1097/JTO.0b013e318241f80b;
2012
Veröffentlicht in: Janssen-Heijnen , M L , van Steenbergen , L N , Steyerberg , E , Visser , O , De Ruysscher , D K & Groen , H J 2012 , ' Long-Term Excess Mortality for Survivors of Non-small Cell Lung Cancer in the Netherlands ' , Journal of Thoracic Oncology , vol. 7 , no. 3 , pp. 496-502 . https://doi.org/10.1097/JTO.0b013e318241f80b;
2012
2
Ten Berge, Deirdre M H J, Aarts, Mieke J, Groen, Harry J M, Aerts, Joachim G J V, Kloover, Jeroen S
Veröffentlicht in: Ten Berge , D M H J , Aarts , M J , Groen , H J M , Aerts , J G J V & Kloover , J S 2022 , ' A population-based study describing characteristics, survival and the effect of TKI treatment on patients with EGFR mutated stage IV NSCLC in the Netherlands ' , European Journal of Cancer , vol. 165 , pp. 195-204 . https://doi.org/10.1016/j.ejca.2022.01.038;
2022
Veröffentlicht in: Ten Berge , D M H J , Aarts , M J , Groen , H J M , Aerts , J G J V & Kloover , J S 2022 , ' A population-based study describing characteristics, survival and the effect of TKI treatment on patients with EGFR mutated stage IV NSCLC in the Netherlands ' , European Journal of Cancer , vol. 165 , pp. 195-204 . https://doi.org/10.1016/j.ejca.2022.01.038;
2022
3
Gijtenbeek, Rolof G.P., Damhuis, Ronald A.M., van der Wekken, Anthonie J., Hendriks, Lizza E.L., Groen, Harry J.M., van Geffen, Wouter H.
Veröffentlicht in: Gijtenbeek , R G P , Damhuis , R A M , van der Wekken , A J , Hendriks , L E L , Groen , H J M & van Geffen , W H 2023 , ' Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands : a retrospective, nationwide registry study ' , The Lancet Regional Health - Europe , vol. 27 , 100592 . https://doi.org/10.1016/j.lanepe.2023.100592;
2023
Veröffentlicht in: Gijtenbeek , R G P , Damhuis , R A M , van der Wekken , A J , Hendriks , L E L , Groen , H J M & van Geffen , W H 2023 , ' Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands : a retrospective, nationwide registry study ' , The Lancet Regional Health - Europe , vol. 27 , 100592 . https://doi.org/10.1016/j.lanepe.2023.100592;
2023
4